{
  "created_at": "Fri Jan 29 4:2:43 +0000 2021",
  "id_str": "1355000639248592897",
  "full_text": "Most middle-income countries will probably not be able to inoculate their most vulnerable citizens until late 2022 https://t.co/OIpqPzasgG",
  "display_text_range": [
    0,
    138
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/OIpqPzasgG",
        "expanded_url": "https://econ.st/3iXt9dk",
        "display_url": "econ.st/3iXt9dk",
        "indices": [
          115,
          138
        ]
      }
    ]
  },
  "user": {
    "name": "The Economist",
    "screen_name": "TheEconomist",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/879361767914262528/HdRauDM-_normal.jpg"
  },
  "retweet_count": 70,
  "favorite_count": 95,
  "possibly_sensitive": false,
  "original_created_at": "Fri Jan 29 03:51:41 +0000 2021",
  "localize": [
    {
      "locale": "zh",
      "full_text": "大多数中等收入国家可能要到2022年底才能为其最脆弱的公民接种疫苗https://t.co/OIpqPzasgG。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "大多數中等收入國家可能要到2022年底才能爲其最脆弱的公民接種疫苗https://t.co/OIpqPzasgG。"
    }
  ]
}